Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2015

Conditions
Hyperemesis GravidarumPregnancy
Interventions
DRUG

Diclectin®

Participants will begin with an initial dose of 20mg (2 tablets), taken at bedtime. The dose of Diclectin® will be adjusted to match symptoms.

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duchesnay Inc.

INDUSTRY

lead

The Hospital for Sick Children

OTHER

NCT00293644 - Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy | Biotech Hunter | Biotech Hunter